{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:13:59Z","timestamp":1790356439608,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41401-025-01533-7","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T04:35:45Z","timestamp":1743482145000},"page":"2482-2495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Licoflavone C as a cap-dependent endonuclease inhibitor against severe fever with thrombocytopenia syndrome virus"],"prefix":"10.1038","volume":"46","author":[{"given":"Xiao","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-shu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-fa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng-fu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","volume":"364","author":"X-J Yu","year":"2011","unstructured":"Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364:1523\u201332.","journal-title":"N Engl J Med."},{"key":"1533_CR2","unstructured":"Current ICTV Taxonomy Release | ICTV. no date."},{"key":"1533_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1203378","volume":"367","author":"LK McMullan","year":"2012","unstructured":"McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367:834\u201341.","journal-title":"N Engl J Med"},{"key":"1533_CR4","doi-asserted-by":"publisher","first-page":"e2014030","DOI":"10.4178\/epih\/e2014030","volume":"36","author":"S Park","year":"2014","unstructured":"Park S, Cho E. National infectious diseases surveillance data of South Korea. Epidemiol Health. 2014;36:e2014030.","journal-title":"Epidemiol Health"},{"key":"1533_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3201\/eid2505.181463","volume":"25","author":"XC Tran","year":"2019","unstructured":"Tran XC, Yun Y, Van An L, Kim SH, Thao NTP, Man PKC, et al. Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg Infect Dis. 2019;25:1029\u201331.","journal-title":"Emerg Infect Dis."},{"key":"1533_CR6","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3201\/eid2607.190611","volume":"26","author":"A Zohaib","year":"2020","unstructured":"Zohaib A, Zhang J, Saqib M, Athar MA, Hussain MH, Chen J, et al. Serologic evidence of severe fever with thrombocytopenia syndrome virus and related viruses in Pakistan. Emerg Infect Dis. 2020;26:1513\u20136.","journal-title":"Emerg Infect Dis"},{"key":"1533_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/1040841X.2020.1847037","volume":"47","author":"J Li","year":"2021","unstructured":"Li J, Li S, Yang L, Cao P, Lu J. Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus. Crit Rev Microbiol. 2021;47:112\u201325.","journal-title":"Crit Rev Microbiol"},{"key":"1533_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jinf.2014.08.001","volume":"70","author":"N Cui","year":"2015","unstructured":"Cui N, Liu R, Lu QB, Wang LY, Qin SL, Yang ZD, et al. Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect. 2015;70:52\u20139.","journal-title":"J Infect"},{"key":"1533_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03664-6","volume":"24","author":"D Shan","year":"2024","unstructured":"Shan D, Chen W, Liu G, Zhang H, Chai S, Zhang Y. Severe fever with thrombocytopenia syndrome with central nervous system symptom onset: a case report and literature review. BMC Neurol. 2024;24:158.","journal-title":"BMC Neurol"},{"key":"1533_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12985-018-1006-7","volume":"15","author":"S Li","year":"2018","unstructured":"Li S, Li Y, Wang Q, Yu X, Liu M, Xie H, et al. Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case. Virol J. 2018;15:97.","journal-title":"Virol J"},{"key":"1533_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12250-016-3931-1","volume":"32","author":"J Zhan","year":"2017","unstructured":"Zhan J, Wang Q, Cheng J, Hu B, Li J, Zhan F, et al. Current status of severe fever with thrombocytopenia syndrome in China. Virol Sin. 2017;32:51\u201362.","journal-title":"Virol Sin"},{"key":"1533_CR12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s40121-022-00693-x","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huang Y, Xu Y. Antiviral treatment options for severe fever with thrombocytopenia syndrome infections. Infect Dis Ther. 2022;11:1805\u201319.","journal-title":"Infect Dis Ther"},{"key":"1533_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/v15040940","volume":"15","author":"L Chen","year":"2023","unstructured":"Chen L, Chen T, Li R, Xu Y, Xiong Y. Recent advances in the study of the immune escape mechanism of SFTSV and its therapeutic agents. Viruses. 2023;15:940.","journal-title":"Viruses"},{"key":"1533_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cmi.2015.07.024","volume":"21","author":"Z Gong","year":"2015","unstructured":"Gong Z, Gu S, Zhang Y, Sun J, Wu X, Ling F, et al. Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China. Clin Microbiol Infect. 2015;21:1115\u201320.","journal-title":"Clin Microbiol Infect"},{"key":"1533_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.7883\/yoken.JJID.2018.526","volume":"72","author":"K Kida","year":"2019","unstructured":"Kida K, Matsuoka Y, Shimoda T, Matsuoka H, Yamada H, Saito T, et al. A case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus. Jpn J Infect Dis. 2019;72:356\u20138.","journal-title":"Jpn J Infect Dis"},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7883\/yoken.JJID.2021.796","volume":"75","author":"H Oshima","year":"2022","unstructured":"Oshima H, Okumura H, Maeda K, Ishijima K, Yoshikawa T, Kurosu T, et al. A patient with severe fever with thrombocytopenia syndrome (SFTS) infected from a sick dog with SFTS virus infection. Jpn J Infect Dis. 2022;75:423\u20136.","journal-title":"Jpn J Infect Dis"},{"key":"1533_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fmicb.2020.00150","volume":"11","author":"M Takayama-Ito","year":"2020","unstructured":"Takayama-Ito M, Saijo M. Antiviral drugs against severe fever with thrombocytopenia syndrome virus infection. Front Microbiol. 2020;11:150.","journal-title":"Front Microbiol"},{"key":"1533_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","volume":"53","author":"MA Casel","year":"2021","unstructured":"Casel MA, Park SJ, Choi YK. Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy. Exp Mol Med. 2021;53:713\u201322.","journal-title":"Exp Mol Med"},{"key":"1533_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1128\/jvi.37.1.72-79.1981","volume":"37","author":"I Ulmanen","year":"1981","unstructured":"Ulmanen I, Sepp\u00e4l\u00e4 P, Pettersson RF. In vitro translation of Uukuniemi virus-specific RNAs: identification of a nonstructural protein and a precursor to the membrane glycoproteins. J Virol. 1981;37:72\u201379.","journal-title":"J Virol"},{"key":"1533_CR20","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1073\/pnas.1603827113","volume":"113","author":"S Halldorsson","year":"2016","unstructured":"Halldorsson S, Behrens A-J, Harlos K, Huiskonen JT, Elliott RM, Crispin M, et al. Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion. Proc Natl Acad Sci USA. 2016;113:7154\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1533_CR21","doi-asserted-by":"publisher","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","volume":"114","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhu Y, Gao F, Jiao Y, Oladejo BO, Chai Y, et al. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci USA. 2017;114:E7564\u2013E7573.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1533_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cell.2015.06.063","volume":"162","author":"K Das","year":"2015","unstructured":"Das K, Arnold E. Negative-strand rna virus L proteins: one machine, many activities. Cell. 2015;162:239\u201341.","journal-title":"Cell"},{"key":"1533_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tim.2019.12.006","volume":"28","author":"S Olschewski","year":"2020","unstructured":"Olschewski S, Cusack S, Rosenthal M. The cap-snatching mechanism of bunyaviruses. Trends Microbiol. 2020;28:293\u2013303.","journal-title":"Trends Microbiol"},{"key":"1533_CR24","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nature07745","volume":"458","author":"A Dias","year":"2009","unstructured":"Dias A, Bouvier D, Cr\u00e9pin T, McCarthy AA, Hart DJ, Baudin F, et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature. 2009;458:914\u20138.","journal-title":"Nature"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"e1001038","DOI":"10.1371\/journal.ppat.1001038","volume":"6","author":"B Morin","year":"2010","unstructured":"Morin B, Coutard B, Lelke M, Ferron F, Kerber R, Jamal S, et al. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog. 2010;6:e1001038.","journal-title":"PLoS Pathog"},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41564-020-0712-2","volume":"5","author":"P Wang","year":"2020","unstructured":"Wang P, Liu L, Liu A, Yan L, He Y, Shen S, et al. Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation. Nat Microbiol. 2020;5:864\u201371.","journal-title":"Nat Microbiol"},{"key":"1533_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6807-7-40","volume":"7","author":"L Knizewski","year":"2007","unstructured":"Knizewski L, Kinch LN, Grishin NV, Rychlewski L, Ginalski K. Realm of PD-(D\/E)XK nuclease superfamily revisited: detection of novel families with modified transitive meta profile searches. BMC Struct Biol. 2007;7:40.","journal-title":"BMC Struct Biol"},{"key":"1533_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00769-24","volume":"0","author":"J Lu","year":"2024","unstructured":"Lu J, Liu J, Wu Y, He X, Gao X, Chen X, et al. A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses. J Virol. 2024;0:e00769-24.","journal-title":"J Virol"},{"key":"1533_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29203","volume":"95","author":"D Kim","year":"2023","unstructured":"Kim D, Lai CJ, Cha I, Kang S, Yang WS, Choi Y, et al. SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge. J Med Virol. 2023;95:e29203.","journal-title":"J Med Virol"},{"key":"1533_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/v16010128","volume":"16","author":"D Kim","year":"2024","unstructured":"Kim D, Lai CJ, Cha I, Jung JU. Current progress of severe fever with thrombocytopenia syndrome virus (SFTSV) vaccine development. Viruses. 2024;16:128.","journal-title":"Viruses"},{"key":"1533_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-021-00541-3","volume":"6","author":"H Li","year":"2021","unstructured":"Li H, Jiang XM, Cui N, Yuan C, Zhang SF, Lu QB, et al. Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome. Signal Transduct Target Ther. 2021;6:145.","journal-title":"Signal Transduct Target Ther"},{"key":"1533_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.celrep.2019.12.020","volume":"30","author":"W Wang","year":"2020","unstructured":"Wang W, Shin WJ, Zhang B, Choi Y, Yoo JS, Zimmerman MI, et al. The cap-snatching SFTSV endonuclease domain is an antiviral target. Cell Rep. 2020;30:153\u2013163.e5.","journal-title":"Cell Rep."},{"key":"1533_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","volume":"49","author":"Y Furuta","year":"2005","unstructured":"Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, et al. Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother. 2005;49:981\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1533_CR34","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/AAC.01219-10","volume":"55","author":"M Mendenhall","year":"2011","unstructured":"Mendenhall M, Russell A, Juelich T, Messina EL, Smee DF, Freiberg AN, et al. T-705 (favipiravir) inhibition of arenavirus replication in cell culture. Antimicrob Agents Chemother. 2011;55:782\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1533_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Y Furuta","year":"2013","unstructured":"Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antivir Res. 2013;100:446\u201354.","journal-title":"Antivir Res"},{"key":"1533_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-virology-111821-120445","volume":"10","author":"CE Hamele","year":"2023","unstructured":"Hamele CE, Spurrier MA, Leonard RA, Heaton NS. Segmented, negative-sense RNA viruses of humans: genetic systems and experimental uses of reporter strains. Annu Rev Virol. 2023;10:261\u201382.","journal-title":"Annu Rev Virol"},{"key":"1533_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coviro.2017.04.003","volume":"24","author":"E Decroly","year":"2017","unstructured":"Decroly E, Canard B. Biochemical principles and inhibitors to interfere with viral capping pathways. Curr Opin Virol. 2017;24:87\u201396.","journal-title":"Curr Opin Virol"},{"key":"1533_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","volume":"160","author":"T Noshi","year":"2018","unstructured":"Noshi T, Kitano M, Taniguchi K, Yamamoto A, Omoto S, Baba K, et al. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Antivir Res. 2018;160:109\u201317.","journal-title":"Antivir Res"},{"key":"1533_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100486","volume":"296","author":"B Todd","year":"2021","unstructured":"Todd B, Tchesnokov EP, G\u00f6tte M. The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor. J Biol Chem. 2021;296:100486.","journal-title":"J Biol Chem"},{"key":"1533_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206104119","volume":"119","author":"S Toba","year":"2022","unstructured":"Toba S, Sato A, Kawai M, Taoda Y, Unoh Y, Kusakabe S, et al. Identification of cap-dependent endonuclease inhibitors with broad-spectrum activity against bunyaviruses. Proc Natl Acad Sci USA. 2022;119:e2206104119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1533_CR41","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1093\/jac\/dkaa337","volume":"75","author":"S Ter Horst","year":"2020","unstructured":"Ter Horst S, Fernandez-Garcia Y, Bassetto M, G\u00fcnther S, Brancale A, Neyts J, et al. Enhanced efficacy of endonuclease inhibitor baloxavir acid against orthobunyaviruses when used in combination with ribavirin. J Antimicrob Chemother. 2020;75:3189\u201393.","journal-title":"J Antimicrob Chemother"},{"key":"1533_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13238-018-0604-x","volume":"10","author":"G Zhang","year":"2019","unstructured":"Zhang G, Cao J, Cai Y, Liu Y, Li Y, Wang P, et al. Structure-activity relationship optimization for lassa virus fusion inhibitors targeting the transmembrane domain of GP2. Protein Cell. 2019;10:137\u201342.","journal-title":"Protein Cell"},{"key":"1533_CR43","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1021\/acs.jmedchem.9b00861","volume":"62","author":"M Miyagawa","year":"2019","unstructured":"Miyagawa M, Akiyama T, Taoda Y, Takaya K, Takahashi-Kageyama C, Tomita K, et al. Synthesis and SAR study of carbamoyl pyridone bicycle derivatives as potent inhibitors of influenza cap-dependent endonuclease. J Med Chem. 2019;62:8101\u201314.","journal-title":"J Med Chem"},{"key":"1533_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.22270\/jddt.v10i4.4218","volume":"10","author":"M Rudrapal","year":"2020","unstructured":"Rudrapal M, Chetia D. Virtual screening, molecular docking and QSAR studies in drug discovery and development programme. J Drug Deliv Ther. 2020;10:225\u201333.","journal-title":"J Drug Deliv Ther"},{"key":"1533_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nchem.2479","volume":"8","author":"T Rodrigues","year":"2016","unstructured":"Rodrigues T, Reker D, Schneider P, Schneider G. Counting on natural products for drug design. Nat Chem. 2016;8:531\u201341.","journal-title":"Nat Chem"},{"key":"1533_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab484","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang Y, Nie W, Luo Y, Deng L. Computational anti-COVID-19 drug design: progress and challenges. Brief Bioinform. 2022;23:bbab484.","journal-title":"Brief Bioinform"},{"key":"1533_CR47","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1002\/anie.201601967","volume":"55","author":"Y Tu","year":"2016","unstructured":"Tu Y. Artemisinin-A gift from Traditional Chinese Medicine to the world (Nobel Lecture). Angew Chem Int Ed Engl. 2016;55:10210\u201326.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1533_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-020-00325-1","volume":"5","author":"C Yang","year":"2020","unstructured":"Yang C, Pan X, Xu X, Cheng C, Huang Y, Li L, et al. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein. Signal Transduct Target Ther. 2020;5:220.","journal-title":"Signal Transduct Target Ther"},{"key":"1533_CR49","doi-asserted-by":"crossref","unstructured":"He X, Yang F, Wu Y, Lu J, Gao X, Zhu X, et al. Identification of tanshinone I as cap-dependent endonuclease inhibitor with broad-spectrum antiviral effect. J Virol. 2023;97:e00796\u201323.","DOI":"10.1128\/jvi.00796-23"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01533-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:16:21Z","timestamp":1757160981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01533-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01533-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}